X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

More than 240 immuno-oncology treatments in development to fight cancer

By Andrew Powaleny  |    June 1, 2017
The American Cancer Society estimates that in 2017 alone, there will be more than 1.6 million new cases of cancer and 600,000 cancer deaths in the United States. With estimates like these, the...   Read More

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

By Andrew Powaleny  |    April 28, 2017
As the understanding of each person’s unique DNA makeup continues to grow (better known as genomics), personalized medicine is rapidly reaching new heights.   Read More

Significant progress fighting cancer: Death rate has dropped 25 percent

By Holly Campbell  |    January 9, 2017
Cancers have long been one of the most devastating and complex disease areas facing patients. But thanks in part to innovative advancements in treatments and early detection, the cancer death rate...   Read More

Building on the promise of personalized medicine

By Andrew Powaleny  |    November 16, 2016
PhRMA’s member companies are on the leading edge of personalized medicine development– an area that is transforming health care, improving patient outcomes and creating health system efficiencies....   Read More

What they are saying about ICER’s scoping document for non-small cell lung cancer

By Holly Campbell  |    July 11, 2016
The Institute for Clinical and Economic Review (ICER) has set its sights on a new target: life-saving treatments for advanced non-small cell lung cancer (NSCLC). ICER’s latest draft scoping...   Read More

New report: Decade of breakthroughs in cancer

By Emma Van Hook  |    June 2, 2016
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving the spread and growth of cancer. These advances are opening new...   Read More

Challenges and opportunities in an era of personalized medicine

By Stephen J. Ubl  |    May 2, 2016
We are at a pivotal time in health care in America. Biomedical discovery and innovation have the potential to revolutionize the way we diagnose and treat patients. At the same time, rapidly...   Read More

Biopharmaceutical Innovation: Antibody drug conjugates

By Andrew Powaleny  |    February 29, 2016
Imagine new medicines that effectively fight cancer, but may result in fewer side effects thanks to more accurate targeting of tumor cells. Today, PhRMA released a new video that highlights these...   Read More

2015: A banner year for personalized medicine

By Emma Van Hook  |    January 22, 2016
2015 was a record year for personalized medicine approvals, according to a new analysis  from the Personalized Medicine Coalition (PMC). This news confirms the growing role of personalized...   Read More

Ensuring personalized medicines reach patients

By Andrew Powaleny  |    November 10, 2015
Personalized medicine is changing the health care landscape for patients by bringing new and innovative treatments to the market. Among the many benefits of personalized medicine, include...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates